Prevalence and pathophysiology of early dumping in patients after primary Roux-en-Y gastric bypass during a mixed-meal tolerance test

Surg Obes Relat Dis. 2019 Jan;15(1):73-81. doi: 10.1016/j.soard.2018.10.004. Epub 2018 Oct 12.

Abstract

Background: Early dumping is a poorly defined and incompletely understood complication after Roux-en-Y gastric (RYGB).

Objective: We performed a mixed-meal tolerance test in patients after RYGB to address the prevalence of early dumping and to gain further insight into its pathophysiology.

Setting: The study was conducted in a regional hospital in the northern part of the Netherlands.

Methods: From a random sample of patients who underwent primary RYGB between 2008 and 2011, 46 patients completed the mixed-meal tolerance test. The dumping severity score for early dumping was assessed every 30 minutes. A sum score at 30 or 60 minutes of ≥5 and an incremental score of ≥3 points were defined as indicating a high suspicion of early dumping. Blood samples were collected at baseline, every 10 minutes during the first half hour, and at 60 minutes after the start.

Results: The prevalence of a high suspicion of early dumping was 26%. No differences were seen for absolute hematocrit value, inactive glucagon-like peptide-1, and vasoactive intestinal peptide between patients with or without early dumping. Patients at high suspicion of early dumping had higher levels of active glucagon-like peptide-1 and peptide YY.

Conclusion: The prevalence of complaints at high suspicion of early dumping in a random population of patients after RYGB is 26% in response to a mixed-meal tolerance test. Postprandial increases in both glucagon-like peptide-1 and peptide YY are associated with symptoms of early dumping, suggesting gut L-cell overactivity in this syndrome.

Keywords: Early dumping; Gastric bypass; Gastrointestinal hormones; Incretins; Pathophysiology; Prevalence.

MeSH terms

  • Adult
  • Cohort Studies
  • Dumping Syndrome / epidemiology*
  • Dumping Syndrome / physiopathology*
  • Female
  • Gastric Bypass / adverse effects*
  • Gastrointestinal Hormones / blood
  • Humans
  • Male
  • Meals / physiology
  • Middle Aged
  • Obesity, Morbid / surgery*
  • Prevalence

Substances

  • Gastrointestinal Hormones